Stephanie R. Forschner-Dancause, Ph.D. - Publications
Affiliations: | 2012 | Pharmaceutical Sciences | University of Rhode Island, Providence, RI, United States |
Area:
Marine natural productsYear | Citation | Score | |||
---|---|---|---|---|---|
2019 | Meschwitz SM, Teasdale ME, Mozzer A, Martin N, Liu J, Forschner-Dancause S, Rowley DC. Antagonism of Quorum Sensing Phenotypes by Analogs of the Marine Bacterial Secondary Metabolite 3-Methyl--(2'-Phenylethyl)-Butyramide. Marine Drugs. 17. PMID 31266202 DOI: 10.3390/Md17070389 | 0.556 | |||
2016 | Forschner-Dancause S, Poulin E, Meschwitz S. Quorum Sensing Inhibition and Structure-Activity Relationships of β-Keto Esters. Molecules (Basel, Switzerland). 21. PMID 27463706 DOI: 10.3390/molecules21080971 | 0.441 | |||
2013 | Graff JR, Forschner-Dancause SR, Menden-Deuer S, Long RA, Rowley DC. Vibrio cholerae Exploits Sub-Lethal Concentrations of a Competitor-Produced Antibiotic to Avoid Toxic Interactions. Frontiers in Microbiology. 4: 8. PMID 23386845 DOI: 10.3389/Fmicb.2013.00008 | 0.604 | |||
2013 | Prieto-Davó A, Villarreal-Gómez LJ, Forschner-Dancause S, Bull AT, Stach JE, Smith DC, Rowley DC, Jensen PR. Targeted search for actinomycetes from nearshore and deep-sea marine sediments. Fems Microbiology Ecology. 84: 510-8. PMID 23360553 DOI: 10.1111/1574-6941.12082 | 0.572 | |||
2012 | Forschner-Dancause S, LaPlante K, Smith DC, Rowley DC. Going deep for drug discovery: an ocean to bedside approach to explore sub-seafloor microbes for the next generation of antibiotics. Medicine and Health, Rhode Island. 95: 292-3. PMID 23094427 | 0.534 | |||
2011 | Teasdale ME, Donovan KA, Forschner-Dancause SR, Rowley DC. Gram-positive marine bacteria as a potential resource for the discovery of quorum sensing inhibitors. Marine Biotechnology (New York, N.Y.). 13: 722-32. PMID 21152942 DOI: 10.1007/S10126-010-9334-7 | 0.561 | |||
Show low-probability matches. |